RayzeBio And Genentech Show Interest In Radiopharmaceuticals Continues To Grow
Similarities With ADC Boom, But Manufacturing A Challenge
RayzeBio's IPO and Genentech's first buy-in into the field show a wave of next-generation companies hoping to expand the radiopharmaceutical field.
